Recently completed
Misalignment between U.S. disease burden and novel therapy innovation may contribute to an increase in U.S. disease prevalence, morbidity, and premature mortality, and may exacerbate existing health disparities. Closing existing gaps between clinical therapy innovation and unmet population health needs through public and private actions may help reduce health disparities, improve health outcomes, and lower societal costs.
Events
Meeting
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People